Se6+.

Selenate has to be reduced to selenite and then to selenide before its selenium can enter selenoprotein synthesis, and the glutathione-dependent reduction chain is what carries out the later steps. That consumes reduced glutathione. Glutathione then also serves as the substrate for the selenoenzymes that result.

Selenate, sulfate and molybdate are structurally similar tetrahedral oxyanions and are known to compete for the same anion transport systems in plants and microorganisms. Whether that competition is meaningful at the micrograms used in a human supplement has not been established. The row is mechanistic and should be read that way.

Ascorbate reduces selenite to insoluble elemental selenium, an interaction well described for the plus-four salt. Selenate is more resistant to that direct reduction, which is one reason formulators may choose it in an ascorbate-rich blend. The comparison is chemical rather than a measured absorption study in people.

N-acetylcysteine supplies cysteine for glutathione synthesis, and glutathione runs the reduction chain that turns inorganic selenium into usable selenide. Cysteine supply therefore sits upstream of selenium activation. This is a substrate relationship, not a direct chemical pairing.

Every selenocysteine residue is built from a serine already loaded onto its tRNA, using selenophosphate derived from reduced selenium. Serine supplies the carbon skeleton and selenium supplies the substituted atom. The two converge on one assembly step.

Selenocysteine beta-lyase, the pyridoxal-5-phosphate enzyme that releases selenide from selenocysteine, is what allows the body to recycle selenium into new selenoproteins. B6 status therefore sits on the recycling loop rather than on absorption. This is settled enzymology.

Glutathione peroxidases are selenoenzymes that clear lipid hydroperoxides after they form, while tocopherol interrupts the radical chain that generates them in the membrane. They act at consecutive points on one sequence, which is the long-standing rationale for pairing them. The complementarity is mechanistic and not a claim about a measured outcome.

The deiodinase enzymes that convert thyroid hormone between its forms are selenoproteins, so normal thyroid hormone handling needs both iodine as substrate and selenium as the catalytic element. Supplying one without the other leaves the pair incomplete. Both carry defined upper intake levels, so total intake is the number to watch.

Zinc and copper superoxide dismutase generates the hydrogen peroxide that selenium-dependent glutathione peroxidase then removes. The two nutrients occupy consecutive positions on a shared handling chain. That is positional complementarity, not one amplifying the other.

Thioredoxin reductase is a selenoenzyme capable of reducing ubiquinone back to ubiquinol, which links selenium status to the recycling of the coenzyme Q pool. That gives a chemical basis for pairing the two in a formula. The link is enzymatic and has not been read out as a clinical result here.

Sodium selenate is one of the compounds a general selenium declaration can refer to. Listing a specific selenate ingredient alongside a general selenium entry means both count toward the same requirement and the same upper limit. Total elemental selenium across the whole regimen is what matters.

Methionine competes with selenomethionine at the amino acid transporter, but selenate is an oxyanion and does not use that route, so the competition does not apply to it. The distinction is worth stating because a label that says only selenium does not tell a formulator which behaviour applies. This is a contrast between forms rather than a pairing.